Found vs. Hims/Hers GLP-1 comparison visual: insurance-first clinical coordination on one side and direct-to-consumer telehealth access on the other.
Last updated: August 18, 2026
Article type: Comparison
Primary keyword: Found vs. Hims/Hers GLP-1
Slug: found-vs-hims-hers-glp-1-2026-insurance-direct-to-consumer
Found and Hims/Hers are both rated Strong Choice by GLP-1 Reviews, but they organize care around different patient priorities. Found’s GLP-1 review emphasizes insurance coordination, prior authorization help, metabolic lab testing, dietitian access, and coaching, while the Hims/Hers GLP-1 review emphasizes direct-to-consumer access, a broad medication menu, a $39 first month, and 24/7 app access. The better fit depends on whether your priority is insurance-first care coordination or a more direct membership-and-medication model.
At-a-glance comparison
| Category | Found | Hims/Hers |
|---|---|---|
| GLP-1 Reviews rating | 4.4/5 : Strong Choice | 4.0/5 : Strong Choice |
| Care model | Insurance-first GLP-1 care with prior authorization help | Direct-to-consumer GLP-1 membership model |
| Published pricing | $149–$399 per month | $39 first month, then $149 per month membership plus medication |
| Out-of-pocket pricing | Exact amount depends on insurance coverage and plan selection | Medication is priced separately from the membership |
| Insurance orientation | Insurance-first, with prior authorization help | Direct-to-consumer access rather than an insurance-first workflow |
| Clinical support | Metabolic lab testing, dietitian access, and coaching support included | 24/7 app access; no lab testing or dietitian included |
| Medication access | Insurance-first access model | Ozempic, Wegovy, Zepbound, compounded semaglutide, and generic liraglutide |
| Business and reputation signals | Provider score and tier are documented on the live review page | Publicly traded as HIMS, Novo Nordisk partnership, and 3.0/5 Trustpilot rating across 8,000+ reviews |
| Best-fit scenario | Patients who want insurance navigation and broader care support | Patients who prefer direct digital access and medication flexibility |
Source: Found review and Hims/Hers review, retrieved August 18, 2026. Ratings use the GLP-1 Reviews methodology.
The central difference: care pathway, not just medication
The most important difference between Found and Hims/Hers is the structure around the prescription.
Found is built around an insurance-first pathway. That means the patient experience gives greater weight to insurance coverage, prior authorization support, metabolic lab testing, dietitian access, and coaching. The published Found review lists monthly costs of $149–$399, but the exact out-of-pocket amount depends on the patient’s insurance coverage and selected plan.
Hims/Hers takes a more direct-to-consumer approach. Its published membership price is $39 for the first month, followed by $149 per month, with medication charged separately. Its model also prioritizes a wide medication menu and 24/7 app access, while the live review page states that lab testing and dietitian access are not included.
Neither model is automatically appropriate for every patient. Insurance coordination can be valuable when coverage is available, but it may introduce additional steps. A direct membership model can feel simpler, but the patient may need to manage more of the clinical and monitoring process outside the membership.
How GLP-1 Reviews rates the two platforms
GLP-1 Reviews uses a published weighted methodology rather than a single subjective editorial ranking. The methodology evaluates providers across authenticity, clinical quality, trust and transparency, reputation, access, support, value, and consumer protection.
Under that methodology:
- Found: 4.4/5, Strong Choice
- Hims/Hers: 4.0/5, Strong Choice
The Strong Choice tier means a provider is generally reliable, with meaningful strengths and minor tradeoffs. These labels are not a declaration that one platform is universally better. They are a summary of the documented provider attributes and the scoring framework described in the GLP-1 Reviews provider methodology.
The scores should therefore be read alongside the care model. Found’s 4.4 rating aligns with its stronger documented clinical-support features, while Hims/Hers’s 4.0 rating reflects strong access and medication flexibility alongside limitations in included labs, dietitian support, and public customer-service signals.
Found vs. Hims/Hers GLP-1 care model comparison: Found emphasizes insurance and clinical support, while Hims/Hers emphasizes direct digital access and medication flexibility.
Found pricing: $149–$399 per month, with insurance affecting the final amount
The live Found review lists monthly costs of $149–$399. That range is described as mid-to-high compared with the wider GLP-1 telehealth market.
The important qualification is that the published range should not be treated as a universal final bill. Found’s insurance-first model means a patient’s out-of-pocket cost depends on:
- Whether the patient’s insurance is accepted.
- Whether the prescribed medication is covered.
- Whether the insurer requires prior authorization.
- Which Found plan the patient selects.
- Whether the patient uses insurance or self-pay options.
The live review specifically identifies prior authorization help as part of Found’s insurance-oriented model. That can matter for patients whose insurer requires documentation before approving a prescription. However, prior authorization assistance does not guarantee approval. Coverage decisions remain dependent on the insurer’s rules and the patient’s plan.
Found’s price range also needs to be evaluated alongside what is included. The published review identifies:
- Metabolic lab testing.
- Dietitian access.
- Coaching support.
- Insurance coordination.
- Access to a structured GLP-1 care program.
A higher monthly price can represent a different level of service when it includes clinical and behavioral support. It should not be compared with a membership-only price without checking what each provider includes.
Questions to ask before choosing Found
Before enrolling, ask Found to clarify:
- Which part of the monthly price covers the membership or care program?
- What services are included in the selected plan?
- How does insurance affect the final out-of-pocket amount?
- Is prior authorization assistance included for the medication being considered?
- What happens if insurance denies coverage?
- Are lab testing and dietitian access available throughout the membership or only at specific stages?
These questions are particularly important for patients comparing a structured insurance-first pathway with a lower initial membership price elsewhere.
Hims/Hers pricing: $39 first month, then $149 membership plus medication
The live Hims/Hers review lists a $39 first-month price, followed by a $149 per month membership fee, with medication charged separately.
That structure creates two distinct pricing components:
- Membership: $39 for the first month, then $149 per month.
- Medication: Charged separately and dependent on the medication prescribed.
The first-month price is therefore not an all-in GLP-1 treatment cost. It is the introductory membership price. Patients should confirm the medication price before completing enrollment, because the membership and medication are separate parts of the program.
This model may appeal to patients who want a clearly defined digital membership and the ability to review medication options through one platform. It may be less attractive to someone who specifically wants included labs, dietitian services, or insurance-first support.
Hims/Hers also offers 24/7 app access for messaging providers, tracking progress, and managing prescriptions. For patients who prefer app-based communication, that access may be a meaningful part of the program’s value.
What Hims/Hers pricing does and does not tell you
The published membership price tells you the recurring platform fee. It does not, by itself, tell you the final monthly cost of treatment.
Before enrolling, confirm:
- The current medication price for the prescribed option.
- Whether the medication is included in any advertised plan or billed separately.
- Whether the medication is brand-name or compounded.
- Whether the prescription can be filled in your state.
- What happens to access if the membership is canceled.
- Whether follow-up care and prescription management remain available after the introductory month.
The distinction between membership and medication is central to comparing Hims/Hers with Found. Found publishes a broader $149–$399 monthly range tied to its program structure, while Hims/Hers publishes $39 for the first month, then $149 per month for membership plus medication. These figures should not be converted into an invented all-in comparison.
Found vs. Hims/Hers GLP-1 pricing visual: Found lists $149–$399 per month, while Hims/Hers lists $39 for the first month and then $149 per month for membership plus separate medication. Source: GLP-1 Reviews live provider review pages, retrieved August 18, 2026.
Medication access: insurance-first versus direct-to-consumer flexibility
Medication access is another major dividing line.
Found’s insurance-first access model
Found’s live review emphasizes insurance accepted alongside self-pay and prior authorization help. For patients who want to use insurance, this makes the coverage workflow part of the platform’s central value proposition.
The model is particularly relevant for patients who:
- Already have commercial insurance.
- Want help navigating prior authorization.
- Prefer a provider that incorporates insurance into the care pathway.
- Want metabolic lab testing and dietitian access included.
- Prefer coaching support alongside medication management.
Insurance-first access can involve more administrative steps than a direct purchase pathway. Patients may need to provide plan information, wait for insurer review, or respond to requests for documentation. The benefit is that the platform is designed to address those steps rather than leaving the entire process to the patient.
Hims/Hers medication selection
The live Hims/Hers review lists the following medication options:
- Ozempic.
- Wegovy.
- Zepbound.
- Compounded semaglutide.
- Generic liraglutide.
This is a broad menu that includes both brand-name and compounded options. The practical availability of any particular medication can depend on clinical eligibility, state availability, prescribing decisions, and pharmacy fulfillment.
The medication list may make Hims/Hers attractive to patients who want to discuss multiple options within one direct-to-consumer platform. However, medication choice should not be separated from the level of clinical support included with the program.
Patients should ask whether a medication option is:
- FDA-approved for the intended use.
- Brand-name or compounded.
- Available in the patient’s state.
- Included in the advertised price or billed separately.
- Subject to a separate consultation or follow-up requirement.
The Hims/Hers provider review contains the live medication and pricing information used in this comparison.
Clinical model: included support is a meaningful distinction
Found and Hims/Hers differ most clearly in the support services listed as included.
Found includes labs, dietitian access, and coaching
Found’s live review identifies three support features that shape its care model:
- Metabolic lab testing included
- Dietitian access included
- Coaching support
These services position Found as a more structured program rather than a medication-access platform alone. Lab testing may provide clinicians with additional information during care, while dietitian access and coaching address the behavioral and nutritional components of a weight-management plan.
That does not mean every patient will need the same level of support. Some patients may already work with a primary-care clinician, registered dietitian, or other healthcare professional. For those patients, the included features may be less important than price, access, or medication availability.
Hims/Hers provides 24/7 app access but excludes labs and dietitian access
Hims/Hers’s key support feature is 24/7 app access. Patients can use the app to communicate with providers, track progress, and manage prescriptions.
At the same time, the live review states that Hims/Hers does not include lab testing and does not include dietitian access. Patients who want those services may need to arrange them separately.
This creates a clear tradeoff:
- Found emphasizes broader clinical and behavioral support.
- Hims/Hers emphasizes ongoing digital access and a streamlined app experience.
Neither approach should be judged solely by the number of features. The relevant question is whether the included services match the patient’s existing healthcare support and preferred way of managing treatment.
Found vs. Hims/Hers GLP-1 clinical support comparison: Found lists metabolic lab testing, dietitian access, and coaching; Hims/Hers lists 24/7 app access but no included lab testing or dietitian access. Source: GLP-1 Reviews live provider review pages, retrieved August 18, 2026.
Patient experience signals: Hims/Hers has strong institutional markers and mixed public reviews
Hims/Hers has several recognizable business and trust signals:
- Publicly traded status under HIMS.
- A Novo Nordisk partnership.
- A 3.0/5 Trustpilot rating across 8,000+ reviews.
These signals tell different parts of the story.
Its publicly traded status provides institutional context. The Novo Nordisk partnership is another important company-level signal connected to the platform’s brand-name medication offering.
Trustpilot provides a different perspective: a large volume of public customer feedback, with a 3.0/5 rating across more than 8,000 reviews. A rating at that level does not establish that every patient will have a poor experience, but it is a reason to examine customer-service expectations, communication, billing clarity, and prescription management before enrolling.
Found’s live review emphasizes its clinical-support features and insurance-first structure. Because the supplied comparison data does not provide a directly comparable Trustpilot volume and rating for Found, readers should avoid treating the two platforms’ public-review signals as perfectly equivalent.
Patient flow: which process may feel more natural?
Found may suit patients who want a coordinated process
Found’s process may feel more suitable to patients who prefer a structured care pathway that includes insurance questions, prior authorization support, metabolic lab testing, dietitian access, and coaching.
That structure may also mean more information is needed before treatment begins. Patients should expect the insurance component and clinical-support features to be part of the onboarding experience rather than optional extras.
Hims/Hers may suit patients who want digital convenience
Hims/Hers may feel more natural to patients who prefer:
- Direct-to-consumer enrollment.
- A broad medication menu.
- App-based communication.
- 24/7 access to digital care tools.
- A separate membership and medication pricing structure.
The tradeoff is that lab testing and dietitian access are not included in the membership according to the live review. Patients who want those services should plan how they will obtain them independently.
Best for each patient scenario
Best for patients who want insurance-first care
Found is the more closely aligned option for patients who want insurance to play a central role in the care process. Its live review identifies insurance-first support and prior authorization help as defining features.
Best for patients who want prior authorization assistance
Found is the relevant option for patients who specifically want help with prior authorization. Approval is never guaranteed, but the platform’s care model is designed around assisting with the insurance workflow.
Best for patients who want included metabolic lab testing
Found is the better fit for this specific need because metabolic lab testing is listed as included in the live review.
Best for patients who want dietitian access and coaching
Found is the more closely matched option because dietitian access and coaching support are included in its published review attributes.
Best for patients who want a direct digital membership
Hims/Hers may be the better fit for patients who prioritize direct-to-consumer enrollment, app-based access, and a medication menu that includes Ozempic, Wegovy, Zepbound, compounded semaglutide, and generic liraglutide.
Best for patients who want 24/7 app access
Hims/Hers is the more direct match because the live review specifically lists 24/7 app access for provider messaging, progress tracking, and prescription management.
Best for patients who want to compare brand-name and compounded options
Hims/Hers lists both types of options in the live review. Patients should still ask the prescribing clinician which options are clinically appropriate and confirm the current medication price separately from the membership.
What to verify before enrolling with either provider
Pricing and availability can change, so use the live provider pages as the starting point and confirm details during enrollment.
Verify the complete price structure
For Found, confirm how insurance coverage and plan selection affect the final out-of-pocket amount within the published $149–$399 monthly range.
For Hims/Hers, confirm the medication charge in addition to the $39 first-month membership price and the subsequent $149 monthly membership fee.
Verify what clinical services are included
Ask Found how metabolic lab testing, dietitian access, and coaching are delivered and when they become available.
Ask Hims/Hers how patients should arrange lab testing or nutritional support, since those services are not included in the membership according to the live review.
Verify medication availability
Ask whether the medication under consideration is currently available in your state, whether it is brand-name or compounded, and whether it is billed separately.
Verify support and cancellation terms
Before paying, review how provider messaging, prescription management, refills, and membership cancellation work. This is especially important when medication and membership are separate charges.
Related GLP-1 Reviews coverage
For additional provider comparisons, see:
- Mochi Health vs. Sesame GLP-1 costs and access in 2026
- Trim Rx vs. Hims GLP-1 weight-loss programs in 2026
- Ro vs. OrderlyMeds GLP-1 convenience and cost comparison
These comparisons use the same broader goal: separating published provider attributes from marketing claims and avoiding unsupported all-in pricing assumptions.
FAQ
Is Found or Hims/Hers better for GLP-1 weight loss in 2026?
Neither provider is universally better for every patient. Found is the closer fit for insurance-first care, prior authorization help, metabolic lab testing, dietitian access, and coaching. Hims/Hers is the closer fit for direct-to-consumer access, a broad medication menu, 24/7 app access, and a separate membership-plus-medication structure. Both are rated Strong Choice by GLP-1 Reviews under its published methodology.
How much does Found cost per month?
Found’s live GLP-1 review lists monthly costs of $149–$399. The exact out-of-pocket amount depends on insurance coverage and the plan selected. Because Found is insurance-first and offers prior authorization help, patients should confirm how their insurance affects the final cost before enrolling rather than assuming the published range represents one universal bill.
How much does Hims/Hers cost for GLP-1 medication?
Hims/Hers lists a $39 first-month membership price, followed by $149 per month for membership, with medication charged separately. The membership price is therefore not an all-in medication cost. Patients should confirm the current medication charge, medication type, and availability for their state before completing enrollment.
Does Found include lab testing and dietitian access?
Yes. Found’s live review lists metabolic lab testing and dietitian access as included features, along with coaching support. These services are part of the reason Found’s care model may appeal to patients who want more structured support around GLP-1 treatment. Patients should still confirm the timing and scope of each service for the plan they select.
Does Hims/Hers include lab testing or a dietitian?
No. The live Hims/Hers review states that lab testing and dietitian access are not included in the membership. Hims/Hers does provide 24/7 app access for provider messaging, progress tracking, and prescription management. Patients who want laboratory monitoring or nutritional counseling should ask how those services can be arranged separately.
Conclusion: compare the pathway before comparing the price
Found and Hims/Hers represent two different ways to access GLP-1 care in 2026.
Found’s 4.4/5 Strong Choice rating is paired with an insurance-first model, prior authorization help, metabolic lab testing, dietitian access, and coaching. Its published monthly cost is $149–$399, with the exact out-of-pocket amount depending on insurance coverage and plan selection.
Hims/Hers’s 4.0/5 Strong Choice rating is paired with direct-to-consumer access, a $39 first-month membership price, a $149 monthly membership after the first month, and medication billed separately. Its medication menu includes Ozempic, Wegovy, Zepbound, compounded semaglutide, and generic liraglutide. It also offers 24/7 app access, while lab testing and dietitian access are not included.
Use Found when insurance navigation and broader included support are central to your decision. Consider Hims/Hers when direct digital access, medication flexibility, and app-based care are more important. In either case, verify the complete pricing structure and clinical services before enrolling.
This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any medication.
Corrected 9 October 2026. We removed 4 generated images from this article. Generated images on this site no longer show certifications, organisations, products, prices or figures unless the specific claim has been checked.
Corrected 14 October 2026: this article previously gave Better Business Bureau ratings for providers it compares, taken from our April 2026 research. We kept no record of where those ratings came from, so they have been removed.
Keep exploring our GLP-1 resources:
